ILA 3384.0
(2.61%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 20.62 Million | -15.89 Million | -9.97 Million | 5.71 Million | 11.17 Million | -3.77 Million |
Net Income | 6.2 Million | -1.5 Million | 1.51 Million | 2.12 Million | 101 Thousand | -4.15 Million |
Depreciation & Amortization | 7.65 Million | 7.16 Million | 4.29 Million | 3.69 Million | 3.46 Million | 1.79 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 135 Thousand | - | - | - | - | - |
Change in working capital | 2.13 Million | -21.22 Million | -22.23 Million | -8.13 Million | 10.34 Million | -2.88 Million |
Other non-cash items | 4.48 Million | -325 Thousand | 6.45 Million | 8.03 Million | -2.74 Million | 1.47 Million |
Investing Cash Flow | -1.41 Million | -4.17 Million | -11.51 Million | -8.93 Million | 7.64 Million | 4.46 Million |
Investments in PPE | -1.88 Million | -1.78 Million | -5.85 Million | -9.09 Million | -2.68 Million | -1.55 Million |
Acquisitions | - | - | -5.87 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 474 Thousand | -2.39 Million | 215 Thousand | 163 Thousand | 10.32 Million | 6.02 Million |
Financing Cash Flow | -8.19 Million | 13.58 Million | 16.78 Million | 3.24 Million | -11.7 Million | -638 Thousand |
Debt repayment | -5.06 Million | -1.8 Million | -1.15 Million | -3.24 Million | -1.5 Million | - |
Dividends payments | - | - | -1.77 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.12 Million | 15.39 Million | 19.72 Million | 3.24 Million | -10.2 Million | -638 Thousand |
Accounts receivables | 8.34 Million | -13.05 Million | -19.41 Million | -13.63 Million | -1.3 Million | -2.34 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | 3.03 Million | -15.01 Million | -10.92 Million | 7.52 Million | 2.21 Million | 5.91 Million |
Other working capital | -9.24 Million | 6.85 Million | 8.09 Million | -2.03 Million | 9.43 Million | -6.45 Million |
Cash at beginning of period | 4.08 Million | 10.17 Million | 14.7 Million | 15.04 Million | 8.25 Million | 7.94 Million |
Cash at end of period | 14.91 Million | 4.08 Million | 10.17 Million | 14.7 Million | 15.04 Million | 8.25 Million |
Capital Expenditure | -1.88 Million | -1.78 Million | -5.85 Million | -9.09 Million | -2.68 Million | -1.55 Million |
Effect of forex changes on cash | -185 Thousand | 389 Thousand | 172 Thousand | -368 Thousand | -323 Thousand | 251 Thousand |
Net cash flow / Change in cash | 10.83 Million | -6.09 Million | -4.52 Million | -338 Thousand | 6.78 Million | 308.99 Thousand |
Free Cash Flow | 18.73 Million | -17.67 Million | -15.82 Million | -3.38 Million | 8.49 Million | -5.32 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 5.28 Million | 4.3 Million | 6.2 Million | 1.89 Million | -1.5 Million | - |
Depreciation & Amortization | 3.31 Million | 4.24 Million | 7.65 Million | 3.41 Million | 7.16 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 37 Thousand | 135 Thousand | 135 Thousand | - | - | - |
Change in working capital | -6.44 Million | 8.14 Million | 2.13 Million | -6 Million | -21.22 Million | - |
Other non-cash items | 7.82 Million | 3.73 Million | 4.48 Million | 746 Thousand | -325 Thousand | - |
Investing Cash Flow | -1.66 Million | -518 Thousand | -1.41 Million | -893 Thousand | -4.17 Million | - |
Investments in PPE | -1.82 Million | -844 Thousand | -1.88 Million | -1.04 Million | -1.78 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 165 Thousand | 326 Thousand | 474 Thousand | 147.99 Thousand | -2.39 Million | - |
Financing Cash Flow | -15.82 Million | -8.85 Million | -8.19 Million | 665 Thousand | 13.58 Million | - |
Debt repayment | -2.83 Million | - | -5.06 Million | -2.37 Million | -1.8 Million | - |
Dividends payments | -4.5 Million | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -8.49 Million | -8.85 Million | -3.12 Million | 3.03 Million | 15.39 Million | - |
Accounts receivables | 11.34 Million | 409 Thousand | 8.34 Million | 7.93 Million | -13.05 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | -16.05 Million | 7.97 Million | 3.03 Million | -4.94 Million | -15.01 Million | - |
Other working capital | -1.73 Million | -243 Thousand | -9.24 Million | -9 Million | 6.85 Million | - |
Cash at beginning of period | 14.91 Million | 3.95 Million | 4.08 Million | 4.08 Million | 10.17 Million | 6.18 Million |
Cash at end of period | 7.21 Million | 14.91 Million | 14.91 Million | 3.95 Million | 4.08 Million | 6.18 Million |
Capital Expenditure | -1.82 Million | -844 Thousand | -1.88 Million | -1.04 Million | -1.78 Million | - |
Effect of forex changes on cash | -223 Thousand | -237 Thousand | -185 Thousand | 52 Thousand | 389 Thousand | - |
Net cash flow / Change in cash | -7.7 Million | 10.96 Million | 10.83 Million | -127 Thousand | -6.09 Million | - |
Free Cash Flow | 8.17 Million | 19.72 Million | 18.73 Million | -991.99 Thousand | -17.67 Million | - |
IBIO
MONOF
9706
VRE
ECORF
688613